Our vaccine highly effective against variants prevalent in India, suitable for 12 yrs, above: Pfizer
India | May 26, 2021 23:17 ISTSeeking a fast-track approval for its COVID-19 vaccine, US major Pfizer has told Indian authorities that its jab has shown "high effectiveness" against the SARS-CoV-2 variant prevalent in India and on people of Indian ethnicity or nationality, while it is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees, sources said on Wednesday.